Tag Archives: SPX
Preempting Goldman Sachs’ Conviction Buy List and Other Sell Side Upgrades As a Matter of Habit
We have noted on numerous occasions that it is not uncommon for stocks that appear in our model portfolios or our weekly ranking updates to presage major ratings actions by sell side firms. See our “Nostradamus Report” and “Getting in … Continue reading
Biogen Idec An Attractive Biotech Name
Biogen Idec Inc. (BIIB) is a $15.8b market cap biotechnology company that “discovers, develops, manufactures and markets biological products for the treatment of serious diseases with a focus on neurological disorders.” Biogen Idec was formed in November 2003 when IDEC … Continue reading
GrafTech International Ltd. — Looking Good but Not Great
GTI looks good, but not good enough to make it into our model portfolios. As experienced investors know, there are plenty of exceptions to any quantitative rule. Our models tend to work well on average over time from the standpoint … Continue reading
Getting in Before Sell Side Institutions Follow
We have noted on numerous occasions that it is not uncommon for stocks that appear in our model portfolios or our weekly ranking updates to presage major ratings actions by sell side firms. See our “Nostradamus Report” for more details. … Continue reading
RPC Inc the Most Intriguing Idea this Week
RPC Inc. (RES) is a $2.6b market cap oil and gas services company that offers technical and support services to other oil and gas companies. It operates in two segments, Technical Services and Support Services. Technical Services include pressure pumping, … Continue reading
High-Quality Continues to Beat S&P 500 Performance
Model Portfolio Daily Update: November 4, 2010 Members must log in for the full report: Members that have problems logging in and view the report, please contact us. [emember_protected] http://scr.bi/dePNpn [/emember_protected] New Actions Required: [emember_protected] None [/emember_protected] Of Note: A … Continue reading
Executing Real Trades Relative to a Theoretical Model Involves High Risk of Slippage Costs
Ascendere Model Portfolio Daily Update: November 1, 2010 Members may log in for the full report: [emember_protected] http://bit.ly/bHRQ2c [/emember_protected] New Actions Required: None. Of Note: Fundamentals are sharply improving and valuations remain compelling As of October 31, 2010, 24 stocks … Continue reading
Maybe CREE’s Shortfall Wasn’t Really a Surprise
This daily update is a supplement to a monthly report dated September 30, 2010 that details the model portfolio strategies of Ascendere Associates LLC (“Ascendere”). Today’s detailed report is available here. Daily-Ascendere-2010-10-19 New Actions Required: None Of Note: The market … Continue reading
Ascendere Daily Update — Oct 14, 2010 — “Foreclosure Gate” Driving AGO 27%+ MTD
Additional Details: Daily-Ascendere-2010-10-14 New Actions Required: A long position in Assured Guaranty Ltd. (AGO) surpassed its price target of $21.14 and will be assumed closed at the end of trading tomorrow. A short position in Liberty Media Capital (LCAP.A) closed … Continue reading
Is DeVry the Next Private Equity Target?
The market sold off early on Thursday, July 15, 2010, due to manufacturing indices showing significant slowing in growth offsetting a positive data point in new unemployment claims. Our short position was starting to look good. But by the end … Continue reading
